APOB and metabolic syndrome: Individuals in the high‐VAT group exhibited systemic metabolic disturbances, with significantly elevated conventional CVD risk markers including WC, BMI, TG, and ApoB, consistent with VAT's established role as a core component of metabolic syndrome [7, 8].